Recursion Pharmaceuticals (RXRX) ended the recent trading session at $3.53, demonstrating a +2.02% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 0.56%.

If you are trying to figure out whether Recursion Pharmaceuticals is attractively priced or a high risk speculation, a useful ...

Recursion will host a (L)earnings Call on February 25, 2026 at 8:00 am ET / 6:00 am MT / 1:00 pm GMT. The company will broadcast the live stream from Recursion’s X, LinkedIn, and YouTube accounts.

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI ...

Recursion Pharmaceuticals granted inducement RSU awards to 17 new employees under its 2024 Inducement Equity Incentive Plan. The awards are tied to recent hiring activity and are intended as ...

Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, 2026, the Compensation Committee of Recursion's Board of ...

Nvidia added positions in struggling rival Intel ( INTC ), chip design software maker Synopsys ( SNPS ), and Finnish telecom Nokia ( NOK ). Synopsys shares climbed about 6% in recent trading, while ...

AI’s rise feels faster and deeper than past tech shifts—reshaping not just what we build, but how we build, learn, and evolve in an accelerating feedback loop.

Lloyd Coombes is an experienced freelancer in tech, gaming and fitness seen at Polygon, Eurogamer, Macworld, TechRadar and ...

The arrival of modular blockchains and ZK proofs have reduced verification times to seconds for executing transactions with ...

AI has become a must-have for cybersecurity teams and not just because vendors are adding AI to everything. It enables deeper ...

Dead languages aren't as unimportant as they seem, because learning Latin, Sanskrit and Ancient Greek will make coding easier ...